Top Markets
#1 Cortex Cortex +33.66%
#2 Seeker Seeker +20.06%
#3 Ethena Staked ENA Ethena Staked ENA +10.21%
#4 Official Trump Official Trump +9.41%
#5 EXOD EXOD +9.04%
#6 peaq peaq +8.30%
#7 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +7.70%
#8 MarsCoin MarsCoin +7.36%
#9 Solstice Solstice +6.35%
#10 Versatize Coin Versatize Coin +5.26%
Coin of the day
Cortex Cortex
Settings
Language
ENGLISH
Currency
USD
Theme
BELLUS Health Inc. BELLUS Health Inc.

BELLUS Health Inc.

BLU
Rank in Stocks #6891
BELLUS Health Inc. is a biopharmaceutical firm in the clinical development... BELLUS Health Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to creating new therapeutic options for intractable chronic cough (RCC) and various other conditions characterized by heightened cough sensitivity. The company's primary investigational compound, BLU-5937, functions as a P2X3 receptor antagonist. This drug is currently progressing through Phase II clinical trials, where it is being assessed for its potential in treating both RCC and persistent itching. Founded in 1993, BELLUS Health Inc. is headquartered in Laval, Canada.
Share Price
$14.30
Last synced: 2023-06-29
Market Cap
$1.81B
Change (1 day)
-2.81%
Change (1 year)
0.00%
Country
CA
Trade BELLUS Health Inc. (BLU)

Category

Healthcare
Number of shares outstanding for BELLUS Health Inc. (BLU)
Number of shares outstanding as of August 2026: 0
According to BELLUS Health Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for BELLUS Health Inc. (BLU) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH